BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11439732)

  • 21. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities.
    Locke GR; Zinsmeister AR; Talley NJ; Fett SL; Melton LJ
    Am J Gastroenterol; 2000 Jan; 95(1):157-65. PubMed ID: 10638576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers.
    Faresjö A; Grodzinsky E; Foldevi M; Johansson S; Wallander MA
    Aliment Pharmacol Ther; 2006 Mar; 23(6):807-14. PubMed ID: 16556183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organic colonic lesions in patients with irritable bowel syndrome (IBS).
    Akhtar AJ; Shaheen MA; Zha J
    Med Sci Monit; 2006 Sep; 12(9):CR363-7. PubMed ID: 16940928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome.
    Lacy BE; Rosemore J; Robertson D; Corbin DA; Grau M; Crowell MD
    Scand J Gastroenterol; 2006 Aug; 41(8):892-902. PubMed ID: 16803687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Budget impact of tegaserod on a managed care organization formulary.
    Bloom MA; Barghout V; Kahler KH; Bentkover J; Kurth H; Gralnek IM; Spiegel BM
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria.
    Hamm LR; Sorrells SC; Harding JP; Northcutt AR; Heath AT; Kapke GF; Hunt CM; Mangel AW
    Am J Gastroenterol; 1999 May; 94(5):1279-82. PubMed ID: 10235207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease.
    Posserud I; Svedlund J; Wallin J; Simrén M
    J Psychosom Res; 2009 May; 66(5):399-405. PubMed ID: 19379956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An epidemiologic study of irritable bowel syndrome in Beijing - a stratified randomized study by clustering sampling].
    Pan G; Lu S; Ke M; Han S; Guo H; Fang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):26-9. PubMed ID: 11860753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment goals in irritable bowel syndrome.
    Kellow JE
    Int J Clin Pract; 2001 Oct; 55(8):546-51. PubMed ID: 11695076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidity in irritable bowel syndrome.
    Whitehead WE; Palsson OS; Levy RR; Feld AD; Turner M; Von Korff M
    Am J Gastroenterol; 2007 Dec; 102(12):2767-76. PubMed ID: 17900326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
    Ringel Y; Williams RE; Kalilani L; Cook SF
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
    Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
    Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
    Chang L
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and physiological sleep characteristics in women with irritable bowel syndrome.
    Elsenbruch S; Thompson JJ; Hamish MJ; Exton MS; Orr WC
    Am J Gastroenterol; 2002 Sep; 97(9):2306-14. PubMed ID: 12358249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
    Ruigómez A; García Rodríguez LA; Panés J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.
    Heymann-Mönnikes I; Arnold R; Florin I; Herda C; Melfsen S; Mönnikes H
    Am J Gastroenterol; 2000 Apr; 95(4):981-94. PubMed ID: 10763948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence and risk factors of the development of irritable bowel syndrome in adolescents: a population study].
    Reshetnikov OV; Kurilovich SA; Denisova DV; Zav'ialova LG; Svetlova IO; Tereshonok IN; Krivenchuk NA; Eremeeva LI
    Ter Arkh; 2001; 73(2):24-9. PubMed ID: 11338849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnosis of IBS in primary care: consensus development using nominal group technique.
    Rubin G; De Wit N; Meineche-Schmidt V; Seifert B; Hall N; Hungin P
    Fam Pract; 2006 Dec; 23(6):687-92. PubMed ID: 17062586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.